Literature DB >> 2035685

Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules.

K Ley1, M Cerrito, K E Arfors.   

Abstract

Before firm adhesion, leukocytes roll slowly along the walls of small venules at velocities ranging from 0.7 to 36% of mean blood flow velocity. To investigate the nature of the adhesive process underlying leukocyte rolling, synthetic (dextran sulfate) and naturally occurring sulfated polysaccharides (heparin, chondroitin sulfates, keratan sulfate, and heparan sulfate) were infused via glass micropipettes into the lumen of small venules (20-60 microns diam) of the rabbit mesentery. Leukocyte rolling was observed and quantified using both transmitted light and incident fluorescence intravital microscopy. Rolling leukocytes accounted for 27-80% of total leukocyte flux, exhibiting a wide range of individual velocities (0.01-0.84 mm/s) with a mean value of 4% of centerline velocity. Dextran sulfate (Mr 500,000) inhibited leukocyte rolling very effectively [half-effective concentration (ED50) approximately 10 micrograms/ml] and was able to almost completely abolish rolling at 500 micrograms/ml. Heparin (ED50 approximately 50 micrograms/ml), chondroitin 6-sulfate C (ED50 approximately 500 micrograms/ml), and heparan sulfate (ED50 approximately 5 mg/ml) also reduced leukocyte rolling. At 5 mg/ml, chondroitin 4-sulfate B (dermatan sulfate) was marginally effective, but chondroitin 4-sulfate A and keratan sulfate were ineffective. The present data suggest that an adhesion receptor-ligand system distinct from the leukocyte integrins may be underlying transient leukocyte adhesion (rolling). Endothelial glycoproteins or proteoglycans containing sulfated side chains may be involved in mediating this adhesive process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035685     DOI: 10.1152/ajpheart.1991.260.5.H1667

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  26 in total

1.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.

Authors:  Rachel E Miller; Alan J Grodzinsky; Kiersten Cummings; Anna H K Plaas; Ada A Cole; Richard T Lee; Parth Patwari
Journal:  Arthritis Rheum       Date:  2010-12

2.  Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo.

Authors:  U H von Andrian; J D Chambers; L M McEvoy; R F Bargatze; K E Arfors; E C Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.

Authors:  Helen Jones; William Paul; Clive P Page
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion.

Authors:  P Kubes; M Jutila; D Payne
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 5.  Role of the endothelial surface layer in neutrophil recruitment.

Authors:  Alex Marki; Jeffrey D Esko; Axel R Pries; Klaus Ley
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

6.  Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin.

Authors:  Toshiaki Iba; Akio Kidokoro; Masaki Fukunaga; Kunihiko Nagakari; Masaru Suda; Seiichiro Yoshikawa; Yukiko Ida
Journal:  Intensive Care Med       Date:  2005-07-02       Impact factor: 17.440

7.  Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin.

Authors:  Herbert H Lipowsky; Anne Lescanic
Journal:  Microvasc Res       Date:  2017-03-27       Impact factor: 3.514

8.  The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells.

Authors:  A Smailbegovic; R Lever; C P Page
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease.

Authors:  Alison E John; Nicholas W Lukacs; Aaron A Berlin; Aiyappa Palecanda; Robert F Bargatze; Lloyd M Stoolman; Jon O Nagy
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.